Chemfab Alkalis Ltd

Chemfab Alkalis Ltd has issued a revised copy of its 17th Annual General Meeting (AGM) notice to correct typographical errors in the serial numbering of special business agenda items. The original notice incorrectly listed 'Ratification of Cost Auditor's Remuneration' and 'Payment of Commission to Non-Executive Directors' as items 4 and 5, respectively. These have now been corrected to items 5 and 6. The AGM is scheduled for September 9, 2026, at 10:00 AM IST, to be held via Video Conferencing/Other Audio-Visual Means. The agenda includes ordinary business such as adopting financial statements, director retirement/reappointment, dividend declaration, and appointment of statutory auditors, as well as special business concerning the cost auditor's remuneration and payment of commission to non-executive directors.

Chemfab Alkalis Ltd has submitted a revised notice of its 17th Annual General Meeting (AGM) for the financial year 2025-26. The revision is due to typographical errors in the serial numbering of agenda items under 'Special Business'. Specifically, 'Ratification of Cost Auditor's Remuneration' was incorrectly numbered as '4' and 'Payment of Commission to Non-Executive Directors' as '5', instead of the correct sequence of '5' and '6'. The company has provided an amended notice and enclosed the revised Annual Report, which includes the corrected AGM notice. The AGM is scheduled for September 9, 2026, at 10:00 AM IST, to be held via Video Conferencing/Other Audio-Visual Means.

Chemfab Alkalis Ltd has submitted correspondence regarding the dispatch of letters to shareholders whose email IDs are not registered. These letters provide a web-link to access the Annual Report for FY 2025-26, in compliance with SEBI (LODR) Regulations, 2015. The company also announced its 17th Annual General Meeting (AGM) will be held on September 9, 2026, via Video Conferencing. The AGM notice and Annual Report for FY 2025-26 are being sent electronically to shareholders with registered email addresses. Shareholders are urged to register their KYC details.

Chemfab Alkalis Ltd has announced that September 2, 2026, has been fixed as the record date for determining shareholder eligibility to receive the final dividend for the financial year 2025-26. This dividend will be declared at the company's 17th Annual General Meeting (AGM), scheduled for September 9, 2026. The announcement was made in compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Chemfab Alkalis Limited has submitted its Annual Report for the Financial Year 2025-26, coinciding with the announcement of its 17th Annual General Meeting (AGM). The AGM is scheduled for September 9, 2026, to be held via Video Conferencing. The report details the company's performance in its two core segments: Chlor Alkali and OPVC Pipes, highlighting their essential role in industrial and water infrastructure. It also includes forward-looking statements, risk factors, and details on corporate responsibility initiatives. The Annual Report is available on the company's website.

Chemfab Alkalis Ltd has announced its 17th Annual General Meeting (AGM) will be held on September 9, 2026, at 10:00 AM IST via Video Conferencing. The company also released a calendar of events for the AGM, including remote e-voting from September 5th to 8th, 2026. Key agenda items include the adoption of financial statements for the year ended March 31, 2026, the reappointment of director Mr. Suresh Krishnamurthi Rao, and the declaration of a dividend of ₹125 per equity share. Additionally, the appointment of M S K C & Associates LLP as statutory auditors for five years and the ratification of remuneration for cost auditors M/s. Madhavan, Mohan & Associates for FY 2026-27 are on the agenda.

Chemfab Alkalis Ltd announced the appointment of M/s. MSKA & Associates LLP as its new Statutory Auditors for a term of five years, subject to shareholder approval at the upcoming AGM. This appointment follows the expiry of the tenure of the current auditors, Deloitte Haskins & Sells LLP. The Board of Directors also approved the Un-Audited Standalone and Consolidated Financial Results for the quarter ended June 30, 2026, along with the Limited Review Report. The board meeting was held on July 29, 2026.

Chemfab Alkalis Ltd announced that its Board of Directors, in a meeting held on July 29, 2026, approved the Un-Audited Standalone and Consolidated Financial Results for the quarter ended June 30, 2026. The Board also approved the appointment of M/s. M S K A & Associates LLP as the Statutory Auditors for a five-year term, subject to shareholder approval at the upcoming AGM. This appointment follows the expiry of the tenure of the current auditor, Deloitte Haskins & Sells LLP.

Chemfab Alkalis' consolidated revenue fell to Rs.73.16 Cr, down 20.1% YoY and 2.2% QoQ, while reported PAT of Rs.5.73 Cr looks like a strong +124.9% YoY jump. That headline is misleading: a Rs.3.80 Cr one-off deferred-tax credit (Note 4) - booked after the company re-measured its opening deferred tax liability following an election of the concessional tax rate under the new Income Tax Act 2025 - drove most of the gain. Stripping it out, adjusted PAT is roughly Rs.1.93 Cr, down about 24% YoY, which tracks a near-53% YoY drop in profit before tax (Rs.2.22 Cr vs Rs.4.70 Cr) far better than the reported PAT figure does. The revenue and PBT declines are a segment-mix story. Chemicals & Related Products revenue grew 27.6% YoY (Rs.67.41 Cr vs Rs.52.84 Cr) and the segment swung to a Rs.2.92 Cr profit from a Rs.3.72 Cr loss a year ago, but PVC-O Pipes revenue collapsed 85.1% YoY (Rs.5.75 Cr vs Rs.38.70 Cr) and its result flipped from an Rs.8.63 Cr profit to a Rs.0.57 Cr loss, dragging the consolidated top line down even as the core chemicals business improved. Operating profitability actually expanded - EBITDA margin rose to 13.84% from 12.34% YoY and 11.39% QoQ on the richer chemicals mix - but finance cost (+40.7% YoY to Rs.2.21 Cr) and depreciation (+21.7% YoY to Rs.7.78 Cr), tied partly to Rs.14.91 Cr invested this quarter under a hybrid power-purchase agreement, ate into that gain before tax. There is no consensus estimate or formal management guidance on record for this micro-cap - a web search turned up no Q1 FY27 preview or brokerage estimates, and our records hold no prior concall or outlook - so vs-street and vs-guidance cannot be assessed beyond 'unknown'. Standalone (parent-only) results show the same tax-credit effect with a much thinner underlying base: PBT of just Rs.1.30 Cr and PAT of Rs.4.83 Cr, indicating the subsidiaries (Chemfab Karaikal, Chemfab Hiitech Piping) supply most of the incremental consolidated profit. Separately, the board approved MSKA & Associates as incoming statutory auditor for a five-year term succeeding Deloitte Haskins & Sells, effective from the next AGM - a governance item unrelated to the quarter's numbers. Going forward, the tax credit was a one-time item that will not recur, so the PBT trend (down YoY this quarter) is the cleaner read on underlying performance: whether the chemicals segment's turnaround holds without it, and whether PVC-O Pipes stabilizes, will determine if consolidated profit growth becomes genuine rather than tax-driven.

Chemfab Alkalis Ltd has announced that its Board of Directors will convene on July 29, 2026, to consider and approve the un-audited standalone and consolidated financial results for the quarter ended June 30, 2026. The trading window for the company's shares will remain closed from July 1, 2026, until 48 hours after the declaration of these financial results, extending until July 31, 2026, in compliance with SEBI regulations.